Evidence map›Paper›PMID 41920372›Full record

ArticleVeterinary research communications2026

Enhancing Alcelaphine gammaherpesvirus 1 propagation in the MDBK cell line: role of ruxolitinib and reduced incubation temperature.

Hana Malenovská

Abstract read
In one paragraph

Article in Veterinary research communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Hana MalenovskáCollection of Animal Pathogenic Microorganisms, Veterinary Research Institute, Hudcova 70, 621 00, Brno, Czech Republic. hana.malenovska@vri.cz.ORCID http://orcid.org/0000-0002-7297-5857

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alcelaphine gammaherpesvirus 1 (AlHV-1) is the causative agent of malignant catarrhal fever, a fatal disease of cattle prevalent in regions with wildebeest populations. In vitro isolation and propagation of AlHV-1 is laborious and often requires multiple passages to improve the visibility of the cytopathic effect in host cells and increase virus yields. Ruxolitinib increases the replication of some viruses due to inhibition of the IFN-induced antiviral response of infected cells. In this study, the effect of a ruxolitinib-enriched culture medium was tested simultaneously with the effect of a reduced incubation temperature (33 °C) on the propagation of the AlHV-1 strain WC-11 adapted to the MDBK cell line. Ruxolitinib significantly increased the destruction of the cell monolayer during AIHV-1 propagation and significantly increased the virus titre. In addition, the amount of cell-free AIHV-1 particles in the culture medium was enhanced significantly in the presence of ruxolitinib. A reduced incubation temperature (33 °C), either in combination with ruxolitinib-enriched medium or without ruxolitinib, had no significant effect on AIHV-1 growth. These results demonstrate that ruxolitinib enhances the propagation of AlHV-1 strain WC-11 and suggest a broader potential to improve the efficiency of AlHV-1 cell culture-based applications, such as virus isolation, vaccine production, and diagnostics.

Indexed as

GammaherpesvirinaePyrazolesVirus CultivationVirus ReplicationAnimalsCattleCell LineNitrilesPyrimidinesTemperatureNitrilesPyrazolesPyrimidinesruxolitinibAlcelaphine gammaherpesvirus 1MDBKRuxolitinibVirus propagation

Identifiers

PMID41920372
PMCPMC13043591

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.